Prime Medicine PRME Number of Vested and Expected to Vest Options

Number of Vested and Expected to Vest Options at other companies

Lesaka Technologies, Inc.LSAK

$1.11M+24.9%

Northwest BancsharesNWBI

$9K-95.3%

Quantum Computing Inc.QUBT

23.6K—

Esperion TherapeuticsESPR

$4.75M+39,500%

BillionToOne, Inc. BLLN

$614.21M—

TFS FinancialTFSL

$1.55M—

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's number of vested and expected to vest options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's number of vested and expected to vest options?: Prime Medicine (PRME) reported number of vested and expected to vest options of 20.9M in Q1 2026.
How has Prime Medicine's number of vested and expected to vest options changed year-over-year?: Prime Medicine's number of vested and expected to vest options increased by 36.2% year-over-year, from 15.3M to 20.9M.